Abstract:Introduction Genome-wide association studies (GWAS) have identified >60 genomic loci for lung cancer risk. However, causal genes and the underlying biological mechanisms for most of these loci remain unknown. Therefore, we conducted a multi-omics study to identify lung cancer susceptibility genes. Method We first conducted a transcriptome-wide association study (TWAS) using S-PrediXcan framework. Whole transcriptome data from adjacent-normal lung tissue samples and genomic data from 304 European-ancestry lung cancer patients were used to build genetic prediction models for expression levels of protein-coding genes and lincRNAs. The prediction models were then applied to GWAS meta-analysis results for lung cancer with 39,363 cases and 621,480 controls of European descents from TRICL-ILCCO, the UK Biobank, and FinnGen. COJO was used to assess whether those significant genes were independent of proximal (±1.5 Mb) GWAS-identified risk variants. To replicate our TWAS-identified genes, we used data from GTEx version 8 normal lung tissue (N=444) to build imputation models and then run association analyses. We acquired gene (N=107) and protein expression data (N=111) from tumor and matched adjacent-normal lung tissues from European-ancestry participants in the Clinical Proteomic Tumor Analysis Consortium. Paired Wilcoxon rank sum tests were then conducted to assess whether identified genes and their corresponding proteins were expressed differentially. Results Out of 18,850 genes (read count >6 and TPM >0.1 in at least 20% samples), 6,754 protein-coding genes and 802 lincRNAs were predicted reliably using genetic variants (R>0.1 and P<0.05). Among them, genetically proxied expression levels of 24 genes located at 15 loci were significantly associated with lung cancer risk at a Bonferroni adjusted P <0.05. Four genes were located at four novel loci, including SERF1A at 5q13.2, SMIM33 at 5q31.2, MUC5B at 11p15.5, and RASSF10 at 11p15.2. Six putative candidate genes, namely H4C13, HCP5B, STN1, COPS2, SKIV2L, and LINC00243 resided in previously GWAS-identified lung cancer loci but have not been reported. Of these six genes, SKIV2L (Padjust=1.49e-5) and LINC00243 (Padjust=3.47e-5) were independently associated with lung cancer risk even after adjusting for GWAS-identified variants. Among 24 identified genes, 16 showed a consistent significant association with lung cancer risk (p<0.05) based on the prediction models built using GTEx data. Of ten unreported or novel genes, MUC5B, SMIM33, SERF1A, STN1, COPS2, and LINC00243 showed differential gene expression at P <0.05 and consistent association direction with TWAS results. Three proteins, STN1, COPS2, and SKIV2L, showed differential expression in tumor and adjacent-normal tissue at P<0.05, which is consistent with our TWAS direction. Conclusion Our findings offer novel insights into lung cancer carcinogenesis by uncovering new genes and loci. Citation Format: Shuai Xu, Yaohua Yang, Tianying Zhao, Jiajun Shi, Jie Ping, Wanqing Wen, Hui Cai, Xingyi Guo, Ran Tao, Xiao-Ou Shu, Wei Zheng, Jirong Long, Qiuyin Cai. Multi Omics analyses identified novel loci and genes for lung cancer risk among European Descendants [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB146.

Associations Between Genetic Variants in Mrna Splicing-Related Genes and Risk of Lung Cancer: a Pathway-Based Analysis from Published GWASs

Deciphering Associations Between Three RNA Splicing-Related Genetic Variants and Lung Cancer Risk

SNP rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Genetic variants cis -regulating Xrn2 expression contribute to the risk of spontaneous lung tumor

Supplementary Data from Genome-Wide Splicing Quantitative Expression Locus Analysis Identifies Causal Risk Variants for Non–Small Cell Lung Cancer

Integrating Expression-Related SNPs into Genome-Wide Gene- and Pathway-Based Analyses Identified Novel Lung Cancer Susceptibility Genes.

Genetic Variations in Cancer-Related Significantly Mutated Genes and Lung Cancer Susceptibility.

Susceptibility Loci of CNOT6 in the General Mrna Degradation Pathway and Lung Cancer Risk—a Re‐analysis of Eight GWASs

Abstract 1174: Genetic Variations in Microrna Biogenesis Pathway Genes As Susceptibility Loci for Lung Cancer Risk

Systematic Analyses of Regulatory Variants in DNase I Hypersensitive Sites Identified Two Novel Lung Cancer Susceptibility Loci

A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer.

Genetic Variants of PTPN2 Are Associated with Lung Cancer Risk: a Re-Analysis of Eight GWASs in the TRICL-ILCCO Consortium

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

Genetic Variant in DNA Repair Genegtf2h4is Associated with Lung Cancer Risk: a Large-Scale Analysis of Six Published GWAS Datasets in the TRICL Consortium

Abstract 7002: RNA m6A modification and lung cancer risk: An epitranscriptome-wide association study

A Functional Genetic Variant in Microrna-196A2 is Associated with Increased Susceptibility of Lung Cancer in Chinese.

Genetic control of alternative splicing and its distinct role in colorectal cancer mechanisms

rs66651343 and rs12909095 confer lung cancer risk by regulating CCNDBP1 expression

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Abstract LB146: Multi Omics analyses identified novel loci and genes for lung cancer risk among European Descendants

Data from A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer